Ontario Best Practices Research Initiative
Real-world evidence for better arthritis care
OBRI is an Ontario-based research registry and academic initiative that collects long-term, real-world data to improve treatment and outcomes for people living with rheumatoid arthritis and psoriatic arthritis.
Who We Are
Improving arthritis care through real-world evidence
The Ontario Best Practices Research Initiative (OBRI) was founded in 2005 through the cooperative efforts of patients, rheumatologists, and researchers. Based at the University Health Network in Toronto, OBRI operates one of Canada's largest longitudinal rheumatoid arthritis registries.
Originally created as the Ontario Biologics Research Initiative, the registry was officially renamed in 2013 to reflect the expansion of OBRI's goals beyond the scope of biologic treatments. Through the collaborative efforts of physicians, payers, researchers, and patients, OBRI has grown to include 91 sites (both community and academic) and over 3,500 patients.
OBRI's unique platform integrates clinical data from rheumatologists, patient-reported data from participants, and administrative data from ICES to monitor comparative drug safety, effectiveness, and patient quality of care.
Real-World Research
We collect long-term data from patients in everyday clinical settings — not controlled trials — to reflect how treatments actually work.
Patient Partnership
Patients have been partners in OBRI since its founding, contributing their expertise and lived experience at every stage of research.
Evidence for Policy
Our findings inform provincial drug policy, clinical guidelines, and treatment decisions for thousands of Ontarians.
Our Mission & Mandate
Improving care through real-world evidence
To improve the care and health outcomes for Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) patients by gathering and analyzing long-term information on therapies, clinical practice patterns, and health care utilization in the real world.
- Define the safety, effectiveness, and sustainability of available RA and PsA therapies in the real world
- Identify clinical practice patterns that improve patient health outcomes
- Use real-world clinical data to inform health care decisions
- Generate outcome data related to pharmacotherapy, disease activity, practice patterns, and population health
- Provide leadership in best practices for ethics, data management, real-world data analysis, and administrative database validation
- Inform provincial drug policy and improve access to effective treatments across Canada
Our Value Proposition: OBRI has evolved into a powerful decision-making tool used to shape and inform the future of arthritis care. The rich source of clinical data collected by OBRI can be combined with provincial administrative health data to carry out research on real-world outcomes. Our research is vetted through scientific rigor and the active involvement of a Clinical Advisory Committee so that it may be used by policy makers to influence health care and clinical treatment decisions.
Are you living with rheumatoid arthritis?
By joining OBRI, you help build the real-world evidence that improves rheumatoid arthritis treatment for patients across Ontario and Canada.
